Predictors of sedentary status in overweight and obese patients with multiple chronic conditions: a cohort study
Authors Joven MH, Croghan IT, Quigg SM, Ebbert JO, Takahashi PY
Received 7 April 2017
Accepted for publication 7 August 2017
Published 3 October 2017 Volume 2017:8 Pages 203—209
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Akshita Wason
Peer reviewer comments 2
Editor who approved publication: Professor David B Price
Mark H Joven, Ivana T Croghan, Stephanie M Quigg, Jon O Ebbert, Paul Y Takahashi
Division of Primary Care Internal Medicine, Mayo Clinic, Rochester, Minnesota, MN, USA
Purpose: Walking may improve health in obese patients with multimorbidity. We aimed to identify predictors associated with achieving <5000 steps per day after 4 months.
Patients and methods: We conducted a cohort study of 125 adult patients with a body mass index >25 kg/m2 and ≥7 comorbidities. We evaluated potential predictors for <5000 steps per day using logistic regression and adjusting for age >65 years and sex.
Results: The mean (range) age was 63.6 (20.3–89.8) years. Daily step counts <5000 at baseline showed the highest risk of <5000 daily steps at 4 months (odds ratio [OR] 31.82, 95% confidence interval [CI]: 12.14–95.50). Other significant characteristics were physical quality of life (OR 6.21, 95% CI: 2.32–18.54), gait speed <1 m/s (OR 2.57, 95% CI: 1.18–5.71), age ≥65 years (OR 2.21, 95% CI: 1.05–4.77), waist circumference ≥102 cm (OR 2.48, 95% CI: 1.05–6.06), and body mass index ≥30 kg/m2 (OR 2.69, 95% CI: 1.20–6.26).
Conclusion: New models to increase walking may be required for higher-risk patients.
Keywords: multimorbidity, obesity, pedometer, walking
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]